72 related articles for article (PubMed ID: 28115952)
1. Long-term outcomes of salvage transurethral high-dose-rate brachytherapy combined with external beam radiation therapy for anastomotic recurrence of prostate cancer after radical prostatectomy: A retrospective analysis.
Watanabe K; Kamitani N; Ikeda N; Kawata Y; Tokiya R; Hayashi T; Miyaji Y; Tamada T; Katsui K
Brachytherapy; 2024; 23(2):179-187. PubMed ID: 38245406
[TBL] [Abstract][Full Text] [Related]
2. Salvage Reirradiation Options for Locally Recurrent Prostate Cancer: A Systematic Review.
Zhong J; Slevin F; Scarsbrook AF; Serra M; Choudhury A; Hoskin PJ; Brown S; Henry AM
Front Oncol; 2021; 11():681448. PubMed ID: 34568012
[TBL] [Abstract][Full Text] [Related]
3. Safety of high-dose-rate brachytherapy in patients with prostate cancer and inflammatory bowel disease: A case series.
Thomas H; Chen JJ; Shaheen H; Sabbagh A; Abdul-Baki H; Chau OW; Malik N; Ayoub A; Hassanzadeh C; Hsu IC; Mohamad O
J Contemp Brachytherapy; 2024 Feb; 16(1):1-5. PubMed ID: 38584887
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging for prostate cancer before radical and salvage radiotherapy: What radiation oncologists need to know.
Couñago F; Sancho G; Catalá V; Hernández D; Recio M; Montemuiño S; Hernández JA; Maldonado A; Del Cerro E
World J Clin Oncol; 2017 Aug; 8(4):305-319. PubMed ID: 28848697
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy in localized prostate cancer: a multicenter analysis evaluating tumor control and late toxicity after brachytherapy and external beam radiotherapy in 1293 patients.
Moll M; Nechvile E; Kirisits C; Komina O; Pajer T; Kohl B; Miszczyk M; Widder J; Knocke-Abulesz TH; Goldner G
Strahlenther Onkol; 2024 Mar; ():. PubMed ID: 38488901
[TBL] [Abstract][Full Text] [Related]
6. Pre-implant magnetic resonance and transrectal ultrasound imaging in high-dose-rate prostate brachytherapy: comparison of prostate volumes, craniocaudal extents, and contours.
Grisotto S; Cerrotta A; Pappalardi B; Carrara M; Messina A; Tenconi C; Valdagni R; Fallai C
J Contemp Brachytherapy; 2018 Aug; 10(4):285-290. PubMed ID: 30237811
[TBL] [Abstract][Full Text] [Related]
7. High-dose-rate Brachytherapy as Adjuvant Local rEirradiation for Salvage Treatment of Recurrent breAst cancer (BALESTRA): a retrospective mono-institutional study.
Vavassori A; Riva G; Cavallo I; Spoto R; Dicuonzo S; Fodor C; Comi S; Cambria R; Cattani F; Morra A; Leonardi MC; Lazzari R; Intra M; Luini A; Galimberti VE; Veronesi P; Orecchia R; Jereczek-Fossa BA
J Contemp Brachytherapy; 2020 Jun; 12(3):207-215. PubMed ID: 32695191
[TBL] [Abstract][Full Text] [Related]
8. Acute toxicity outcomes from salvage high-dose-rate brachytherapy for locally recurrent prostate cancer after prior radiotherapy.
Fang B; McGeachy P; Husain S; Meyer T; Thind K; Martell K
J Contemp Brachytherapy; 2024 Apr; 16(2):111-120. PubMed ID: 38808210
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Basal Cell Carcinoma of the Lower Eyelid With High-Dose-Rate Brachytherapy.
Oliveira CN; Viveiros C; Travancinha C; Mota A; Pino I; Fonseca J; Madaleno T; Labareda M; Santos F; Esteves S
Cureus; 2024 Jan; 16(1):e53067. PubMed ID: 38410314
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the safety and efficacy of high-dose rate brachytherapy for radiorecurrent prostate cancer: a systematic review and meta-analysis.
Shen B; Liu J; Wu D; Guo J
Strahlenther Onkol; 2024 Feb; ():. PubMed ID: 38386054
[TBL] [Abstract][Full Text] [Related]
11. Success of Ultra-low Dose Radiation Therapy for Primary Cutaneous B-cell Lymphoma.
Onyewadume L; McClelland S
Am J Clin Oncol; 2024 May; ():. PubMed ID: 38757158
[TBL] [Abstract][Full Text] [Related]
12. Salvage high-dose-rate interventional radiotherapy (brachytherapy) for locally relapsed prostate cancer after radical prostatectomy and subsequent external irradiation.
Soror T; Melchert C; Rades D; Merseburger AS; Kovács G
J Contemp Brachytherapy; 2023 Jun; 15(3):159-165. PubMed ID: 37425206
[TBL] [Abstract][Full Text] [Related]
13. A Phase 1 Trial of Highly Conformal, Hypofractionated Postprostatectomy Radiation Therapy.
Patel KR; Rowe LS; Schott E; Cooley-Zgela T; Ning H; Turkbey B; Choyke P; Lindenberg L; Mena E; Pinto PA; Zhang Q; Shih J; Salerno KE; Citrin DE
Adv Radiat Oncol; 2022; 7(6):101024. PubMed ID: 36420197
[TBL] [Abstract][Full Text] [Related]
14. A case of CRPC with multiple bladder invasions treated with EBRT followed by HDR-BT boost.
Takagawa Y; Itami J
BJR Case Rep; 2022 Mar; 7(6):20210039. PubMed ID: 35300242
[TBL] [Abstract][Full Text] [Related]
15. Second salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer.
Maenhout M; van Vulpen M; Moerland M; Peters M; Meijer R; van den Bosch M; Nguyen P; Frank S; van der Voort van Zyp J
J Contemp Brachytherapy; 2017 Apr; 9(2):161-166. PubMed ID: 28533806
[TBL] [Abstract][Full Text] [Related]
16. Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy.
Buchser D; Gomez-Iturriaga A; Melcon JI; Casquero F; Llarena R; Cacicedo J; Bilbao P
J Contemp Brachytherapy; 2016 Dec; 8(6):477-483. PubMed ID: 28115952
[TBL] [Abstract][Full Text] [Related]
17. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
18. Fractionated perineal high-dose-rate temporary brachytherapy combined with external beam radiation in the treatment of localized prostate cancer: is lymph node sampling necessary?
Kovács G; Galalae R
Cancer Radiother; 2003 Apr; 7(2):100-6. PubMed ID: 12719039
[TBL] [Abstract][Full Text] [Related]
19. Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer.
Ecke TH; Huang-Tiel HJ; Golka K; Selinski S; Geis BC; Koswig S; Bathe K; Hallmann S; Gerullis H
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834929
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
